A steroid fraction of chloroform extract from bee pollen of Brassica campestris induces apoptosis in human prostate cancer PC-3 cells

被引:56
作者
Wu, Yao-Dong [1 ]
Lou, Yi-Jia [1 ]
机构
[1] Zhejiang Univ, Coll Pharmaceut Sci, Dept Pharmacol & Toxicol, Hangzhou 310031, Peoples R China
关键词
Brassica campestris L; prostate cancer; apoptosis;
D O I
10.1002/ptr.2235
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Bee pollen of Brassica campesirds L. is widely used in China as a natural food supplement and an herbal medicine in strengthening the body's resistance against diseases including cancer. The present study was carried out to investigate the effect of a steroid fraction of chloroform extract from bee pollen of Brassica campestris L. on human cancer cell viability. Our studies show that among nine cancer cell lines of different origin (PC-3, LNCaP, MCF-7, Hela, BEL-7402, BCG-823, KB, A549 and H08910), this steroid fraction displayed the strongest cytotoxicity in human prostate cancer PC-3 cells. The mode of cell death appeared to be apoptosis in PC-3 cells, as shown by flow-cytometric analysis and fluorescence microscopes. Caspase-3 activity was obviously enhanced after the cells were treated with the fraction. A time-dependent decrease in the expression of anti-apoptotic protein Bcl-2 was also observed by Western blot analysis. It is suggested that the steroid fraction could induce cytotoxicity in prostate cancer PC-3 cells by triggering apoptosis. The studies indicate that the steroid fraction of chloroform extract from bee pollen of Brassica campestris L. may be a promising candidate for the treatment of advanced prostate cancer. Copyright (c) 2007 John Wiley & Sons, Ltd.
引用
收藏
页码:1087 / 1091
页数:5
相关论文
共 12 条
[1]   Effects of Turkish pollen and propolis extracts on respiratory burst for K-562 cell lines [J].
Aliyazicioglu, Y ;
Deger, O ;
Ovali, E ;
Barlak, Y ;
Hosver, I ;
Tekelioglu, Y ;
Karahan, SC .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2005, 5 (11) :1652-1657
[2]  
GONG WG, 1991, ZHEJIANG ZHONG YI ZA, V11, P513
[3]   p53 and bcl-2 immunohistochemical alterations in prostate cancer treated with radiation therapy [J].
Huang, A ;
Gandour-Edwards, R ;
Rosenthal, SA ;
Siders, DB ;
Deitch, AD ;
deVere White, RW .
UROLOGY, 1998, 51 (02) :346-351
[4]  
Kaighn M E, 1978, Natl Cancer Inst Monogr, P17
[5]   Caspase-3-generated fragment of gelsolin: Effector of morphological change in apoptosis [J].
Kothakota, S ;
Azuma, T ;
Reinhard, C ;
Klippel, A ;
Tang, J ;
Chu, KT ;
McGarry, TJ ;
Kirschner, MW ;
Koths, K ;
Kwiatkowski, DJ ;
Williams, LT .
SCIENCE, 1997, 278 (5336) :294-298
[6]  
Krajewska M, 1996, AM J PATHOL, V148, P1567
[7]  
MCDONNELL TJ, 1992, CANCER RES, V52, P6940
[8]   Chemotherapy for androgen-independent prostate cancer [J].
Petrylak, DP .
WORLD JOURNAL OF UROLOGY, 2005, 23 (01) :10-13
[9]  
RAFFO AJ, 1995, CANCER RES, V55, P4438
[10]  
REN YH, 2001, SHI PIN YAN JIU YU K, V4, P44